Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRx-102 vs placebo for systemic inflammatory markers in severe adult periodontitis
2004-003755-39Phase 2Completed
- Sponsor
- CombinatoRx
- Start
- Sep 2004
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in periodontitis comparing CRx-102 (dipyridamole + prednisolone) with Placebo (2 arms). Primary endpoint: Primary: Change in serum C-reactive protein (CRP). Started Sep 2004; status: completed.
02
Drugs
prednisolone + dipyridamole
03
Conditions
periodontitis
Beyond the preview
Go deeper on 2004-003755-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-003755-39.